1. Home
  2. CRNX vs SIG Comparison

CRNX vs SIG Comparison

Compare CRNX & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$36.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Signet Jewelers Limited

SIG

Signet Jewelers Limited

HOLD

Current Price

$83.71

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
SIG
Founded
2008
1950
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.1B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
CRNX
SIG
Price
$36.66
$83.71
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$76.75
$111.14
AVG Volume (30 Days)
1.3M
674.9K
Earning Date
05-07-2026
06-02-2026
Dividend Yield
N/A
1.65%
EPS Growth
N/A
974.07
EPS
N/A
7.08
Revenue
$1,039,000.00
$6,247,100,000.00
Revenue This Year
$720.10
$1.39
Revenue Next Year
$184.67
$1.71
P/E Ratio
N/A
$11.48
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$65.20
52 Week High
$57.99
$110.20

Technical Indicators

Market Signals
Indicator
CRNX
SIG
Relative Strength Index (RSI) 45.46 51.02
Support Level $33.19 $80.87
Resistance Level $37.23 $95.53
Average True Range (ATR) 2.17 3.60
MACD -0.18 0.38
Stochastic Oscillator 28.47 71.72

Price Performance

Historical Comparison
CRNX
SIG

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding, and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Outlet. Geographically, it operates in the USA, Canada, the UK, and Ireland, with the maximum revenue from the USA.

Share on Social Networks: